Charles Chiu, Professor of Laboratory Medicine and Medicine, University of California, San Francisco:
This article misinterprets the data presented in our report, which I emphasize is still in the process of peer review and was submitted early as a non peer-reviewed preprint to the medRxiv web site.
1. The claim that “vaccinated individuals are more susceptible to SARS-CoV-2 variant infections (or COVID-19) than unvaccinated (individuals)” is incorrect and is patently false. Our report showed that 81% of COVID cases (1248 out of 1373 cases) were in unvaccinated individuals while only 9% (125 out 1373 cases) were in fully vaccinated individuals. Therefore, in our study, there were approximately 10 times more cases of COVID in unvaccinated individuals than in vaccinated individuals. Our study also focused on vaccine breakthrough cases and showed that infections by “antibody-resistant” variants carrying one or more mutations associated with immune evasion, such as Beta, Gamma, and Delta variants, are overrepresented in vaccine breakthrough cases, while infections in unvaccinated individuals generally reflect the overall distribution of variants circulating in the community at the time, i.e., any variant in the community. However, infection by variants (Alpha, Beta, Gamma, Delta, etc.) comprised most infections overall, both in unvaccinated and unvaccinated individuals.
2. Our study was performed at a time when there was simultaneous circulation of multiple variants of the virus, including some that are relatively resistant to neutralizing antibodies. Vaccination prevents the vast majority of infections, but the small subset of vaccinated individuals (9%) who had breakthrough infections at that time were, not surprisingly, more likely to be infected by these “antibody-resistant” variants.
3. Our study does not support in any way the claims that “vaccine antibodies would suppress natural antibody responses. The vaccine antibodies take control of the immune system and defend only against a targeted virus” and “among vaccinated individuals, a COVID variant virus is not recognized by the specialized antibodies provided by the vaccine, and the natural antibodies have been programmed to stand down”. We did not address these issues in our study. Peer-reviewed published data by others show that although there can be reduced sensitivity of “antibody-resistant” variants such as Delta to antibody neutralization elicited, the full dose of the vaccine is still effective in neutralizing the virus and preventing infection[3,4].
4. Finally, our study also found that there “…were fewer hospital admissions and no deaths in vaccinated patients as compared to unvaccinated patients…” and that “…significantly lower viral RNA loads were observed in asymptomatic breakthrough cases as compared to unvaccinated cases…”, which support vaccination to prevent spread of the virus in the community and decrease the number of hospitalizations and deaths from COVID. The effectiveness of the vaccine in preventing hospitalizations from severe COVID is also reported in other published data[4].
5. Vaccines against SARS-CoV-2 were developed with the primary goal of preventing hospitalizations and deaths from COVID, and they have remained very effective in doing so.
To summarize, these three claims are false and misleading and are not supported by the results of our study.